Which Is a Better Investment: Aurora Cannabis or GrowGeneration?
Aurora Cannabis and GrowGeneration have pulled back significantly from record highs, making the stocks attractive to contrarian investors.
Jan. 11, 2022

Stocks part of the cannabis market may provide investors an opportunity to derive market-beating gains in the upcoming decade. The marijuana sector is poised to expand rapidly especially if cannabis is legalized at the federal level in the U.S. 

Keeping these factors in mind, let's see which marijuana stock between Aurora Cannabis (NYSE: ACB) and GrowGeneration (NASDAQ: GRWG) should be part of your portfolio right now.

Aurora Cannabis: Bull vs. Bear arguments

One of the largest cannabis companies operating in Canada, Aurora Cannabis is valued at a market cap of $1.14 billion. Despite its billion-dollar valuation, ACB stock is trading 96% below record highs and has burnt significant investor wealth in the last three years.

The cannabis giant has been wrestling with widening losses, high inventory levels, a decline in market share, and billion-dollar write-downs which have sent its stock price spiraling downwards. 

In order to stem the cash burn, Aurora Cannabis announced it will focus on the high-margin medical marijuana segment as well as disclosed a business transformation plan to lower its cost structure.

In the fiscal first quarter of fiscal 2022 that ended in September, Aurora Cannabis reported net sales of $60.1 million, a decline of 11% year over year. The company's management now expects to report an adjusted EBITDA profit within the next five quarters. But Aurora Cannabis has consistently failed to deliver on its lofty promises in the past, and the company's recently provided outlook should not sway investors.

In Q1 of fiscal 2022, Aurora Cannabis improved its gross margin by just 1%, but it reported an adjusted EBITDA loss of $12.1 million, compared to its prior-year loss of $19.7 million.

However, there are a few things going right for the company. It's a market leader in Canada's medical marijuana segment, where Aurora's sales rose by 23% year over year to $41 million in Q1. The company's international sales more than doubled as well in the quarter ended in September.

Grow Generation: Bull vs. Bear arguments

GrowGeneration is an ancillary marijuana company valued at a market cap of $665 million. GRWG stock went public in late 2016 and has returned 383% to investors. However, its also down 83% from all-time highs making it the perfect contrarian bet at current prices. 

GrowGeneration owns and operates retail hydroponic and organic gardening stores in the U.S. It ended Q3 with a chain of 62 stores and reported revenue of $332 million in the first nine months of 2021. While top-line more than doubled, its net profit in this period surged by 340% to $17 million.

The company now aims to increase the number of stores to 100 by end of 2023 which should translate to sales growth. Analysts expect GrowGeneration to increase sales by 126% to $438 million in 2021 and by 21% to $529.7 million in 2022. Comparatively, its adjusted earnings is forecast to touch $0.30 per share in 2022, up from $0.11 per share in 2020.

So, which stock is a better buy right now?

It's quite easy to pick a winner between Aurora Cannabis and GrowGeneration. While Aurora Cannabis remains unprofitable and grappling with tepid sales, GrowGeneration is widening its bottom-line and continues to trade at an attractive multiple, making the latter a winning bet for cannabis investors.

Top Ten Stocks To Buy Now
Commit to your future wealth today and join 1000s of subscribers receiving:
  • New stock picked every week out of 60,000 worldwide
  • Ten Foundational stocks to hold until 2034
  • A library of 60 stocks with analysis
  • 10 year Track record of performance
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.







This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.